Association between the presenilin-1 mutation Glu318Gly and complaints of memory impairment

Simon M. Laws, Roger M. Clarnette, Kevin Taddei, Georgia Martins, Athena Paton, Osvaldo P. Almeida, Hans Förstl, Ralph N. Martins*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)


Presenilin-1 mutations account for nearly 50% of all early-onset familial cases of Alzheimer's disease. Most of these mutations are completely penetrant, although the recently described Glu318Gly substitution seems to have only partial penetrance. These findings suggest that the Glu318Gly mutation may work as a genetic risk factor for Alzheimer's disease. We designed the present study to investigate the frequency of this mutation among non-demented volunteers with subjective memory impairment (n = 58) and controls (n = 66). Four (6.8%) subjects with complaints of memory problems, but no controls, carried this mutation. The presence of the Glu318Gly mutation was associated with significantly lower cognitive performance when compared to controls (P = 0.011). However, there was no significant association between the presence of the mutation and the cognitive performance of individuals within the memory complainers group. Follow-up studies should clarify whether the Glu318Gly mutation increases the risk of cognitive decline in later life.

Original languageEnglish
Pages (from-to)55-58
Number of pages4
JournalNeurobiology of Aging
Issue number1
Publication statusPublished - 2002
Externally publishedYes


  • Alzheimer's disease
  • E318G
  • Presenilin-1
  • Subjective memory impairment


Dive into the research topics of 'Association between the presenilin-1 mutation Glu318Gly and complaints of memory impairment'. Together they form a unique fingerprint.

Cite this